The first of seven challenges for which Teva is seeking novel solutions revolves around human-predictive platforms for ...

What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Monday outlined that Weiss executed a sale of 12,300 shares of Teva Pharmaceutical Indus with a total value of ...

Generic drug manufacturer Teva ceased propofol production three weeks after a jury awarded $500 million to a patient who contracted hepatitis C from a procedure in which he received the anesthetic, ...

Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted marketing ...

The tension between regulatory compliance and antitrust exposure in Orange Book patent listings reached a dramatic inflection ...

Teva Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration for the first generic GLP-1 medication for weight loss, the Parsippany-based company announced Aug. 28. The ...

Teva PharmaceuticalTEVA reported better-than-expected second-quarter earnings and narrowed its full-year profit outlook as generic drug sales remain "stable" before the stock market open Wednesday.

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C. Michael White, University of Connecticut (THE CONVERSATION) A generic blood ...

After several notable moves to grow the reach of its biomanufacturing platform in recent months, Antheia is linking arms with ...

See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.